why choose us

First received: August 18, 2023

Clinical Trial: Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Patients With Low Risk, Hormone Responsive Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anatomic Stage 0 Breast Cancer AJCC v8

Study Type: INTERVENTIONAL


Official Title: Prospective Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation in Low-Risk, Hormone-Responsive Breast Cancer

Brief Summary: This phase II trial tests how well accelerated partial breast irradiation (APBI) delivered once per day works in ensuring an acceptable breast appearance in patients with low risk, hormone responsive breast cancer.APBI uses precise radiation beams to kill cancerous cells in a smaller area of the breast (partial breast) instead of the whole breast or chest area as in standard therapy.Additionally, APBI is given in a shorter course of treatment than whole breast radiation therapy, over fewer days instead of several…

Read more